RE: Mcap29 May 2023 15:28
Totally agree but even better (subject to passing of resolutions on at the General Meeting)
The total amount of shares in issue will only be - 62,058,768
Broken down as below -
Retail Offer Shares - 2,267,022
Subscription Shares - 2,740,000
Placing Shares - 28,431,746
Total fundraising shares -33,438,768 (raising £1.6m -£1.7m)
Existing Shares in issue - 28,620, 000
The role out of Mammalian Display service, IMO could be a huge game changer here.
GLA.
New commerical service from OptiMAL® programme
Fusion Antibodies CEO, Adrian Kinkaid said: "We are delighted to be able to announce the successful development of the Mammalian Display technology, an output from our OptiMAL®research programme. As our industry rapidly turns to find new ways to hasten the development of better bio-therapeutics to the clinic, we also anticipate deploying these capabilities to bring AI generated antibody sequences out of world class computer algorithms and into a world class antibody laboratory."